Serum Glucose Levels Research Articles

Anti-Obesity Effect of Ethanolic Extract of Citrus Paradisi and Naringin in HFDInduced Animal Model

The study aimed to assess the effectiveness of Citrus paradisi, and Naringin on high fat diet rats.It must be clarified thatthe correlation between body fat and dietary fat levels, long-term energy intake and expenditure imbalances causes Obesity. Animalmodels have made a significant historical contribution to our understanding of the underlying variables that control the elementsof human energy balance. studies have shown that genetics considerably affect how the body reacts to meals high in fat-derivedenergy. Five sets of six male Wistar rats (120–150g); each group had five animals. Group I (Control), Group II (High Fat Diet),Group III (HFD+Naringin (100mg/kg body weight)), Group IV (HFD + Citrus paradise (500mg/kg body weight), and Group V (HFD+21.67mg/kg body weight) are the study groups (drug control). Physical factors such as body weight, organ weight, fat pad weight,and anthropometric parameters were assessed after introducing a high-fat diet. In addition, serum lipid profiles, glucose, insulin,leptin, and adiponectin levels, among other biochemical indicators, were analyzed. These outcomes would empower Citrus Paradiseand Naringin to be utilized as anti-obesity agents. Haemotoxylin and eosin staining was used to detect histopathological alterationsin adipose tissue. The effect of Citrus paradisi and Naringin treated with HFD-induced animals showed significantly higher (p<0.001*).It was observed by its action in reducing organ weight, blood weight, and serum lipids. This current study evaluated the evidencefor Citrus Paradise's effects on body weight, blood pressure, and lipid profile.

Diagnosis and Acute Management of Hyperglycemic Hyperosmolar Syndrome in Children and Adolescents.

Hyperglycemic hyperosmolar syndrome (HHS) is an indolent process characterized by significantly increased levels of serum glucose, high osmolality, and electrolyte abnormalities. The incidence of HHS has steadily risen in the pediatric population over the past several years. Patients with HHS often present with profound dehydration, fatigue, and early mental status changes. Primary emergency management of HHS involves fluid replacement, hemodynamic support, correcting electrolyte derangements, and addressing complications and underlying illnesses. Insulin is not an initial therapy in HHS and should be considered only after the patient's fluids and electrolytes have been repleted. Unlike in diabetic ketoacidosis, HHS patients are not acidotic, although children may present with mixed HHS/diabetic ketoacidosis syndromes. Complications of HHS include thrombosis, rhabdomyolysis, and, rarely, malignant hyperthermia.

Elucidation of anti-hyperglycemic activity of Psidium guajava L. leaves extract on streptozotocin induced neonatal diabetic Long-Evans rats

BackgroundPsidium guajava L (Guava) belongs to the Myrtaceae family and has been claimed to possess several pharmacological properties including antidiabetic. ObjectiveThis study was designed to evaluate the anti-hyperglycemic activity of P guajava L leaves aqueous extract on neonatal streptozotocin-induced type 2 diabetic model rats. MethodsStreptozotocin was induced (90 mg/kg) intraperitoneally to 48 h old Long Evans rat pups. After three months, 18 male type-2 diabetic model rats were confirmed by OGTT (FG > 7 mmol/L). Therefore, experimental rats were divided into three groups 2) Diabetic water control (10 ml/kg), 3) Gliclazide treated (20 mg/kg), and 4) Extract treated group (1.25g/kg)] Six normal female rats comprised group 1 [Non-diabetic water control (10 ml/kg)]. All rats were treated orally with their respective treatment for 28 consecutive days. Blood samples were collected on 0 days (by tail cut method) and the end day (by cardiac puncture) of the experiment. The anti-hyperglycemic activity was evaluated by measuring fasting glucose, serum insulin, lipid profile, hepatic glycogen content, and intestinal glucose absorption by standard methods. ResultsThe serum glucose level of extract treated group was decreased by 16% as well as significantly (p<0.05) increased the serum insulin level (M±SD, 0 day vs 28thday; 0.319 ± 0.110 vs 0.600 ± 0.348, μg/L). Moreover, the extract-treated group also significantly (p<0.05) enhanced liver glycogen content and inhibited glucose absorption from the upper intestine. Besides, a significant (p < 0.05) reduction of LDL-cholesterol level was found in the extract-treated group (M±SD, 55 ± 33 vs 14 ± 9, mg/dl) compared with baseline values where other groups did not show any statistically remarkable changes. ConclusionCurrent study concludes that P guajava leaves aqueous extract enhances insulin secretion from pancreatic beta-cells and promotes glycogen synthesis in the liver. The extract also inhibits glucose absorption from the upper intestine and improves dyslipidemia to some extent. Therefore, possesses the potential for drug development against T2DM.

Mitigating the impact of winter temperatures on striped catfish (Pangasianodon hypophthalmus) using functional feed additives

AbstractThe drop in temperature during the winter months can lead to a decrease in growth, induce metabolic stress, and increase mortality incidences. The present study evaluated the potential of functional feed additives in mitigating the negative impacts of winter‐rearing conditions in striped catfish (Pangasianodon hypophthalmus). Four test diets were evaluated over a twelve‐week feed trial: (1) zinc‐acetate (Zn‐acetate), (2) selenomethionine (Se‐Met), (3) β‐glucan, and (4) control with no added feed additive. The survival rate in the β‐glucan (95.00%) and Zn‐acetate (93.30%) dietary groups was higher than the control (78.30%) and Se‐Met (85.00%). Fish fed with the β‐glucan had the highest weight gain (20.75% increase), specific growth rate (13.75% increase), and lower feed conversion ratio (9.64 % decrease). However, feed additives did not influence the fatty acid profiles or whole‐body proximate composition. Although, Zn‐acetate and Se‐Met had higher body ash content. Serum cortisol and glucose levels were lower in β‐glucan and Zn‐acetate than in other treatment groups. All feed additives resulted in higher superoxide dismutase, glutathione peroxidase, and catalase activity in the liver and muscle. This study found that β‐glucan and zinc‐acetate can improve cold stress resistance and offer a sustainable strategy for catfish rearing over winter.

Metformin: A New Inhibitor of the Wnt Signaling Pathway in Cancer.

The biguanide drug metformin is widely used in type 2 diabetes mellitus therapy, due to its ability to decrease serum glucose levels, mainly by reducing hepatic gluconeogenesis and glycogenolysis. A considerable number of studies have shown that metformin, besides its antidiabetic action, can improve other disease states, such as polycystic ovary disease, acute kidney injury, neurological disorders, cognitive impairment and renal damage. In addition, metformin is well known to suppress the growth and progression of different types of cancer cells both in vitro and in vivo. Accordingly, several epidemiological studies suggest that metformin is capable of lowering cancer risk and reducing the rate of cancer deaths among diabetic patients. The antitumoral effects of metformin have been proposed to be mainly mediated by the activation of the AMP-activated protein kinase (AMPK). However, a number of signaling pathways, both dependent and independent of AMPK activation, have been reported to be involved in metformin antitumoral action. Among these, the Wingless and Int signaling pathway have recently been included. Here, we will focus our attention on the main molecular mechanisms involved.

Enteral free water vs. parenteral dextrose 5% in water for the treatment of hypernatremia in the intensive care unit: a retrospective cohort study from a mixed ICU.

Effective treatment options for patients with hypernatremia are limited. Free water administration (parenterally or enterally) is the mainstay of treatment but the impact of each strategy on lowering serum sodium (Na) is not known.The purpose of the study was thus toassess the effectiveness of enteral free water vs. parenteral dextrose 5% in water (D5W) in treating ICU-acquired hypernatremia. An electronic medical record-based, retrospective cohort study was conducted in a 30-bed mixed medical-surgical intensive care unit (ICU) in Japan. All adult patients admitted to the ICU from August 2017 to July 2021 were reviewed. After a 2-step exclusion, patients who stayed in the ICU ≥ 24h and received either or both treatments for ICU-acquired hypernatremia (Na ≥ 145mEq/L) constituted the study cohort. The primary outcome was a change in serum Na during the 24h before treatment each day (ΔNa); the secondary outcomes were gastrointestinal complications, serum glucose levels, ICU/hospital mortality, ICU/hospital length of stay, and the duration of mechanical ventilation. Repeated measurements on each patient were addressed using a generalized estimated equation (GEE) for multiple linear regression analysis. Analysis was conducted with R version 4.0.3. In total, 256/6596 (131: D5W, 125: enteral free water) patients were analyzed. Median treatment lasted 6days [3-17] for the D5W group vs 7days [3-14] for the enteral free water group with a total median daily treatment volume of 799 [IQR 299-1221] mL vs. 400 [IQR 262-573] mL. GEE multiple linear regression analysis showed an estimated mean ΔNa per liter of treatment fluid of - 2.25 [95% CI - 2.76 to - 1.74] mEq/L per liter of parenteral D5W vs. - 1.91mEq decrease [95% CI - 2.75 to - 1.07] per liter of enteral free water. Hydrochlorothiazide was the only medication associated with a statistically significant negative ΔNa by- 0.89 [- 1.57 to - 0.21] mEq/L. There were no significant inter-group differences for secondary outcomes. These results suggest that both enteral free water and parenteral D5W are effective for treating ICU-acquired hypernatremia. Parenteral D5W was slightly more effective than enteral free water to lower serum Na levels in patients with ICU-acquired hypernatremia. Not applicable.

Kaempferia parviflora rhizome extract exerts anti-obesity effect in high-fat diet-induced obese C57BL/6N mice.

Kaempferia parviflora (KP) rhizome, also called black ginger, has been used as a herbal medicine for many centuries. This current study was aimed at exploring whether KP rhizome extract (KPE) had anti-obesity effects and the mechanism involved. Five-week-old C57BL/6N male mice were allocated into five groups for 8-week feeding with control diet (CD), high-fat diet (HFD), HFD + 150 mg/kg body weight (BW)/day KPE (HFD+K150), HFD + 300 mg/kg BW/day KPE (HFD+K300), and HFD + 600 mg/kg BW/day KPE (HFD+K600). KPE decreased BW, body fat mass, adipose tissue weight, adipocyte size, and serum levels of glucose, triglycerides, cholesterol, insulin, and leptin in HFD-induced obese C57BL/6N mice. KPE inhibited adipogenesis by decreasing CCAAT/enhancer binding protein α, peroxisome proliferator-activated receptor γ, sterol regulatory element-binding protein-1c, acetyl-CoA carboxylase 1, ATP-citrate lyase, and fatty acid synthase mRNA expression. KPE improved lipolysis by increasing carnitine palmitoyl transferase 1 and hormone-sensitive lipase mRNA expression. These results suggest that KPE may have inhibited HFD-induced obesity by regulating several pathways involved in decreasing adipogenesis and enhancing lipolysis. Thus, the results suggest that KPE (or KP) may be applicable as an anti-obesity agent.

Estimation of serum calcitonin, phosphate, and calcium in type 2 diabetes mellitus

Background and objective: Type two diabetes is known as insulin-independent diabetes mellitus due to body’s inability to respond to insulin and can be managed by lifestyle change and hypoglycemic tablets. This study aimed to compare serum levels of calcitonin, calcium, and phosphate between type two diabetic patients and controls. Methods: The cross-sectional study included 50 patients who have already been diagnosed with type two diabetes mellitus and 50 control subjects without clinical signs of any diseases. The level of serum calcitonin, calcium, and phosphate was estimated for all participants. Results: The mean serum level of calcitonin was (2.35 ± 1.18) pg/mL in the case group, while the mean was (32.91 ± 3.88) pg/mL in the control group (P-value = 0.001). The mean level of serum phosphate was (3.93 ± 0.08) mg/dL and (3.73 ± 0.09) mg/dL in the case and control groups, respectively (P-value = 0.117). The mean serum calcium level was (9.68 ± 0.10) mg/dL in the case group, and it was about (9.67 ± 0.14) mg/dL (P-value = 0.955) in healthy persons. Serum calcitonin was negatively correlated with glycated hemoglobin and serum glucose level. Conclusion: The calcitonin serum level in diabetic patients was significantly lower than in healthy individuals. The level of bone minerals (calcium and phosphate) was not altered in type two diabetic patients when compared with control participants.

Analysis of Serum Chemerin Level in Acanthosis Nigricans Patients: A Case Control Study

Abstract Background Acanthosis nigricans (AN) describes clinically a darkly pigmented thickening skin, which demonstrates epidermal/dermal hyperplasia with orthokeratotic hyperkeratosis and papillomatosis of stratum spinosum with basal layer hyperpigmentation, in the absence of actual acanthosis and melanocytosis in histology. Aim of the Work The aim of our work was assessment of serum concentrations of Chemerin level in obese patients with AN and the healthy control group, as well as evaluation of a possible correlation between chemerin concentrations and metabolic syndrome components. Patients and Methods Our study included 75 subjects, divided into three groups. The first group included 25 obese patients with AN, the second group included 25 obese patients without AN. In addition to the control group which included 25 healthy individuals. Each subject was assessed for blood pressure, body mass index and waist hip ratio. 3ml blood sample was taken from each subject. Lipid profile, serum glucose level, fasting serum insulin were measured. Chemerin concentration was assessed by quantitative ELISA. Results In our study, 100% of the included obese patients with AN and 88% of those without AN had metabolic syndrome. No statistically significant difference between them as regards BMI, SBP, DBP, WHR, fasting Insulin (P &amp;gt; 0.05). However, statistically significant higher levels of serum, Cholesterol, TG, HDL, and LDL were observed in obese patients with AN compared with those without AN (P ≤ 0.001). This result showed that AN is a clinical surrogate for laboratory-determined hyperinsulinemia and insulin resistance indicating the highest risk for type 2 diabetes. Conclusion Acanthosis Nigricans has been demonstrated to be a useful screening marker for obesity and insulin resistance. In addition, there is correlation between chemerin concentrations and acanthosis nigricans. Serum chemerin could be considered one of the metabolic risk factors leading to insulin resistance in metabolic syndrome and may represent a novel marker of these derangement.

Design, optimization, and in vivo evaluation of invasome-mediated candesartan for the control of diabetes-associated atherosclerosis

Atherosclerosis is an inflammatory disease characterized by the accumulation of arterial plaque. Diabetes mellitus stands out as a major risk factor for atherosclerosis. Candesartan is a potent angiotensin II receptor antagonist that enhances arterial blood flow and reduces insulin resistance. However, oral candesartan has limited activity because of its low bioavailability, water solubility, hepatic first-pass degradation, and efficacy. The current study aims to develop nasal candesartan-loaded invasome (CLI) drops to improve candesartan’s permeation, release, and bioavailability as a potential treatment for diabetes-associated atherosclerosis. Design expert software was used to prepare various CLI formulations to determine the impact of the concentrations of ethanol, cineole, and phospholipid. The desirability index was used to estimate the optimized formulation composition to maximize entrapment efficiency and minimize vesicle size. The optimized formulation had a 1% ethanol concentration, a 1.5% cineole concentration, and a 2.32% phospholipid concentration. The selected optimized formulation was then tested in a rat model of diabetes and atherosclerosis to evaluate its activity. The results showed that nasal CLI drops significantly raised serum HDL levels by a ratio of 1.42 and lowered serum glucose, cholesterol, triglycerides, LDL, and VLDL levels by 69.70%, 72.22%, 36.52%, 58.0%, and 65.31%, respectively, compared with diabetic atherosclerotic rats, throwing an insight on the potential for promising anti-diabetic and anti-atherosclerotic activities. Additionally, atherosclerotic lesions were improved in rats treated with CLI, as shown in histopathology. In conclusion, the results of this investigation showed that treatment with nasal CSN-loaded invasome formulation drops prevented the initiation and progression of diabetes-associated atherosclerosis.Graphical

Insulin Resistance in Patients with Acne Vulgaris.

Acne vulgaris presents multifactorial pathogenesis, which may include insulin resistance. To investigate whether insulin resistance is a causative factor in acne vulgaris development, this cohort study and a systematic review were conducted. A cohort of 41 acne vulgaris patients and 47 healthy BMI-matched controls were recruited. Glucose and insulin fasting serum levels were obtained and the HOMA-IR was calculated; insulin resistance was diagnosed in cases with a HOMA-IR value over 2.1. The mean ± SD values for glucose fasting serum level were as follows: 94.88 ± 7.731 (mg/dL) in the study group and 79.51 ± 7.175 (mg/dL) in the controls (p < 0.001). The mean ± SD insulin fasting serum levels were 14.47 ± 6.394 (µIU/mL) and 11.83 ± 4.309 (µIU/mL) (p = 0.059), respectively. The HOMA-IR mean ± SD value calculated for the study group was 3.4 ± 1.49 and, in the control group, it was 2.34 ± 0.909 (p < 0.001). Out of 41 patients, 32 were diagnosed with insulin resistance (78%), and 26 of the 47 controls were diagnosed with IR (55%) (p = 0.026). An insulin resistance diagnosis was statistically more common among the acne patients, compared to the controls. In the articles reviewed in this paper, insulin resistance was found to be more frequent in acne vulgaris patients. Both our study and the papers analyzed in the review indicate that insulin resistance might be an independent factor in acne vulgaris development and should be considered when diagnosing and treating acne.

Correlation of HOMA-IR and HbA1C with hematological parameters in patient with Diabetes mellitus Type II in Kirkuk city

Objective: The aim of this study was to investigate the relationship between hematological parameters and glycemic control in patients with type 2 diabetes mellitus (DM). Materials and Methods: This case-control study included 50 patients with DM and 50 healthy controls. Blood samples were collected from all participants to measure various hematological parameters and serum glucose, insulin, and HbA1c levels. Homeostatic Model Assessment-Insulin Resistance (HOMA-IR) was calculated to evaluate insulin resistance. Statistical analysis was performed to compare the results between the groups and to determine the correlation between hematological parameters and glycemic control. Results: The results showed that serum glucose, insulin, HbA1c, serum potassium, RDW, platelet count, and MID were significantly increased in the DM group compared to the control group, while MCV was significantly decreased. The correlation analysis showed that MID, platelet count, PCT count, and PDW were positively correlated with serum glucose, HbA1c, and HOMA-IR, while MCV was negatively correlated with serum glucose and HbA1c. RBC count, RDW, and PCV were positively correlated with HbA1c and HOMA-IR. Conclusions: The study found that DM type II patients had elevated serum glucose, insulin, HOMA IR, and HbA1C levels, as well as increased serum potassium and MID-range absolute count, and decreased MCV but increased RDW. Platelet count, PCT count, and PDW were positively correlated with serum glucose, HbA1C, and HOMA IR. These hematological parameters may serve as useful markers for assessing glycemic control and insulin resistance in DM type II patients.

Role of High-intensity Interval Training in Developing Healthy Metabolic Obesity by Reducing the Serum Levels of Asprosin, Leptin, and Insulin among Inactive Obese Women

Background and Objectives Obesity-induced metabolic disorders are related to the metabolic syndrome. The present study aimed to assess the effect of high-intensity interval training on body mass index (BMI) and serum levels of leptin, asprosin, insulin, and fasting glucose in inactive obese women. Subjects and Methods In this quasi-experimental research, 24 sedentary obese women were purposefully selected and randomly assigned to two groups of exercise and control(n=12 in each group). The intervention involved three sessions of high-intensity weekly interval training per week for 10 weeks. The control group did not receive any exercise intervention. Fasting blood samples were obtained 24 hours before the commencement of the intervention and 72 hours after the last training session. Statistical analysis involved paired sample t-tests and covariance analysis. Results Based on the results, after the intervention, there was a significant decrease in asprosin (η2=0.352; F=0.390; P=0.003), leptin (η2=0.478; F=19.229; P&lt; 0.001) and insulin (η2=0.681; F=44.828; P&lt;0.001) levels in the intervention group compared to the control group. Nonetheless, no significant difference was observed in BMI and fasting blood glucose (P&gt;0.05). Conclusion As evidenced by the results of this research, high-intensity interval training had positive effects on cytokines related to energy homeostasis and hyperinsulinemia in obese women without causing any weight change.

Glucose levels are not the same for everyone: a real-world big data study evaluating fasting serum glucose levels by sex and age among children.

Understanding the normal range of laboratory values as pertained to different age groups and males or females is paramount in health care delivery. We aimed to assess the distribution of morning fasting serum glucose levels by age and sex in the general population of children using a large-scale population-based cohort. A retrospective study with real-world de-identified data from a large, state mandated health fund in Israel among children aged 2-18 years old between 2006 and 2019. Age, sex, and BMI differences in mean glucose levels were evaluated. Study included 130,170 venous blood samples from 117,411 children, 53.3 % were female. After adjusting for age boys had higher fasting serum glucose levels than girls, with a mean of 89.21±8.66 mg/dL vs. 87.59±8.35 (p<0.001) [4.95±0.48 mmol/L vs. 4.86±0.46]. Compared to the 15 to 18 year-olds (88.49±7.63 mg/dL) [4.92±0.42 mmol/L], 2 to 5 year-olds had lower glucose levels (84.19±10.65, [4.68±0.59] (p<0.001)), 11 to 14 year-olds had higher glucose (90.40±7.42 [5.02±0.41], (p<0.001)) and 6 to 10 year-olds showed no difference (88.45±8.25) [4.91±0.46]. 33.0 % (n=42,991) had a BMI percentile record the same year as their glucose test result. There was a weak yet significant positive association between blood glucose levels and BMI. Our large cohort indicates that boys have slightly higher fasting serum glucose levels than girls, as do adolescents compared to younger children. This finding is important for the delivery of adequate health care, screening for illness and avoiding unnecessary investigations and tests.

Assessment of Hypertensive Patients' Complex Metabolic Status Using Data Mining Methods.

Cardiovascular diseases are among the leading causes of mortality worldwide. Hypertension is a preventable risk factor leading to major cardiovascular events. We have not found a comprehensive study investigating Central and Eastern European hypertensive patients' complex metabolic status. Therefore, our goal was to calculate the prevalence of hypertension and associated metabolic abnormalities using data-mining methods in our region. We assessed the data of adults who visited the University of Debrecen Clinical Center's hospital (n = 937,249). The study encompassed data from a period of 20 years (2001-2021). We detected 292,561 hypertensive patients. The calculated prevalence of hypertension was altogether 32.2%. Markedly higher body mass index values were found in hypertensive patients as compared to non-hypertensives. Significantly higher triglyceride and lower HDL-C levels were found in adults from 18 to 80 years old. Furthermore, significantly higher serum glucose and uric acid levels were measured in hypertensive subjects. Our study confirms that the calculated prevalence of hypertension is akin to international findings and highlights the extensive association of metabolic alterations. These findings emphasize the role of early recognition and immediate treatment of cardiometabolic abnormalities to improve the quality of life and life expectancy of hypertensive patients.

Antidiabetic effect of Ardisia elliptica extract and its mechanisms of action in STZ-NA-induced diabetic rat model via 1H-NMR-based metabolomics

Ethnopharmacological relevanceArdisia elliptica Thunb. (AE) (Primulaceae) is a medicinal plant found in the Malay Peninsula and has been traditionally used to treat diabetes. However, limited studies to date in providing scientific evidence to support the antidiabetic efficacy of this plant by in-vitro and in-vivo models. Aim of the studyTo investigate the anti-hyperglycemic potential of AE through in-vitro enzymatic activities and streptozotocin-nicotinamide (STZ-NA) induced diabetic rat models using proton-nuclear magnetic resonance (1H-NMR)-based metabolomics approach. Materials and methodsAnti-α-amylase and anti-α-glucosidase activities of the hydroethanolic extracts of AE were evaluated. The absolute quantification of bioactive constituents, using ultra-high performance liquid chromatography (UHPLC) was performed for the most active extract. Three different dosage levels of the AE extract were orally administered for 4 weeks consecutively in STZ-NA induced diabetic rats. Physical assessments, biochemical analysis, and an untargeted 1H-NMR-based metabolomics analysis of the urine and serum were carried out on the animal model. ResultsType 2 diabetes mellitus (T2DM) rat model was successfully developed based on the clear separation observed between the STZ-NA induced diabetic and normal non-diabetic groups. Discriminating biomarkers included glucose, citrate, succinate, allantoin, hippurate, 2-oxoglutarate, and 3-hydroxybutyrate, as determined through an orthogonal partial least squares-discriminant analysis (OPLS-DA) model. A treatment dosage of 250 mg/kg body weight (BW) of standardized 70% ethanolic AE extract mitigated increase in serum glucose, creatinine, and urea levels, providing treatment levels comparable to that obtained using metformin, with flavonoids primarily contribute to the anti-hyperglycemic activities. Urinary metabolomics disclosed that the following disturbed metabolism pathways: the citrate cycle (TCA cycle), butanoate metabolism, glycolysis and gluconeogenesis, pyruvate metabolism, and synthesis and degradation of ketone bodies, were ameliorated after treatment with the standardized AE extract. ConclusionsThis study demonstrated the first attempt at revealing the therapeutic effect of oral treatment with 250 mg/kg BW of standardized AE extract on chemically induced T2DM rats. The present study provides scientific evidence supporting the ethnomedicinal use of Ardisia elliptica and further advances the understanding of the fundamental molecular mechanisms affected by this herbal antidote.

Endocrinology of Underweight and Anorexia Nervosa.

More than any other mental illness, the course, prognosis, and therapy of anorexia nervosa are shaped by the physical changes associated with being underweight. This article provides an overview of the endocrine changes associated with malnutrition and underweight. This overview serves as a basis for understanding the other articles in this special issue, which deal with the health risks associated with being underweight. In this context, the differences between underweight in anorexia nervosa and in constitutional thinness are of particular importance in assessing the impact of intentional weight loss. In this context, the regulation of hunger and satiety deserves special interest, as this is the area in which the intentional influence on body weight comes into play. Clinical consequences on, for example, fertility, bone metabolism, the homeostasis of, for example, serum glucose levels, or body temperature have been observed for a long time; nonetheless, the medical responses, apart from vitamin supplementations and advice to gain weight, are still limited. Therefore, emphasis was placed on the potential improvement of outcomes through the administration of central or peripheral hormones. Studies were identified on PubMed via a selection of relevant keywords; original texts that were cited in reviews were studied where it was advantageous. This review found some promising data on bone health and the administration of transdermal oestrogen, which is not yet widely used, as well as distinct hormonal markers to differentiate between CT and AN. We concluded that the continuous efforts to investigate the role of endocrinology in underweight and/or anorexia nervosa lead to outcome benefits and that more and higher-powered studies are needed.

Impact of Heat Stress on Blood, Production, and Physiological Indicators in Heat-Tolerant and Heat-Sensitive Dairy Cows.

Heat stress affects production and health in cows severely. Since it is difficult to define heat-tolerant animals, studies of response to heat stress are important for understanding dairy cows' health and production. However, information on the impact of heat stress on various indicators in heat-tolerant and heat-sensitive cows is sparse. This study aimed to investigate the effects of heat stress (HS) on blood, production, and physiological indicators in heat-tolerant and heat-sensitive cows. A total of 43 dairy cows were used from 9 May to 7 August 2021, under Temperature-Humidity Index (THI) measurements that ranged from 65.9 to 86.7. We identified cows that were tolerant or sensitive to HS based on the slope of the response of physiological and production traits against THI during the HS period by using a clustering method. After HS, serum glucose (Glu), cortisol (COR), 5-hydroxytryptamine (5-HT), and interleukin-6 (IL-6) levels of cows in the heat-tolerant group were lower than in the heat-sensitive group (p < 0.05). With THI as the predictor, the R2 for predicting respiration rate (RR) and body surface temperature (BT) in heat-tolerant cows was 0.15 and 0.16, respectively, whereas the R2 for predicting RR and BT in heat-sensitive cows was 0.19 and 0.18, respectively. There were low to moderate, positive correlations between RR, BT, and MY with THI, with Pearson correlation coefficients ranging from r = 0.11 to 0.4 in the heat-tolerant group, and from r = 0.24 to 0.43 in the heat-sensitive group. There was a low positive correlation between VT and THI, with a Spearman correlation coefficient of r = 0.07 in the heat-sensitive group. The heat-tolerant dairy cows had lower MY losses and had lower MY (p = 0.0007) in mixed models. Heat-tolerant cows with low-stress levels, through upregulating RR rapidly, increased their adaptability to thermal environments. They have better thermoregulation capability; the hypothalamic-pituitary-adrenal (HPA) axis regulated the thermoregulatory in animals by releasing a variety of neurotransmitters and hormones.

Phosphorylation of insulin receptor substrates (IRS-1 and IRS-2) is attenuated following cecal ligation and puncture in mice

BackgroundSepsis is characterized as an insulin resistant state. However, the effects of sepsis on insulin’s signal transduction pathway are unknown. The molecular activity driving insulin signaling is controlled by tyrosine phosphorylation of the insulin receptor β-subunit (IRβ) and of insulin receptor substrate molecules (IRS) -1 and IRS-2.HypothesisCecal ligation and puncture (CLP) attenuates IRβ, IRS-1 and IRS-2 phosphorylation.MethodsIACUC-approved studies conformed to ARRIVE guidelines. CLP was performed on C57BL/6 mice; separate cohorts received intraperitoneal insulin at baseline (T0) or at 23 or 47 h. post-CLP, 1 h before mice were euthanized. We measured levels of (1) glucose and insulin in serum, (2) IRβ, IRS-1 and IRS-2 in skeletal muscle and liver homogenate and (3) phospho-Irβ (pIRβ) in liver and skeletal muscle, phospho-IRS-1 (pIRS-1) in skeletal muscle and pIRS-2 in liver. Statistical significance was determined using ANOVA with Sidak’s post-hoc correction.ResultsCLP did not affect the concentrations of IRβ, IRS-1or IRS-2 in muscle or liver homogenate or of IRS-1 in liver. Muscle IRS-1 concentration at 48 h. post-CLP was higher than at T0. Post-CLP pIRS-1 levels in muscle and pIRβ and pIRS-2 levels in liver were indistinguishable from T0 levels. At 48 h. post-CLP pIRβ levels in muscle were higher than at T0. Following insulin administration, the relative abundance of pIRβ in muscle and liver at T0 and at both post-CLP time points was significantly higher than abundance in untreated controls. In T0 controls, the relative abundance of pIRS-1 in muscle and of pIRS-2 in liver following insulin administration was higher than in untreated mice. However, at both post-CLP time points, the relative abundance of pIRS-1 in muscle and of pIRS-2 in liver following insulin administration was not distinguishable from the abundance in untreated mice at the same time point. Serum glucose concentration was significantly lower than T0 at 24 h., but not 48 h., post-CLP. Glucose concentration was lower following insulin administration to T0 mice but not in post-CLP animals. Serum insulin levels were significantly higher than baseline at both post-CLP time points.ConclusionsCLP impaired insulin-induced tyrosine phosphorylation of both IRS-1 in muscle and IRS-2 in liver. These findings suggest that the molecular mechanism underlying CLP-induced insulin resistance involves impaired IRS-1/IRS-2 phosphorylation.

The effect of long-term strength training on serum levels of betatrophin and irisin in elderly men with type 2 diabetes

Background. The irisin and betatrophin hormones are involved in insulin resistance. Considering the muscle weakness of elderly diabetics, this study aimed to investigate the effect of 21 weeks of strength training on betatrophin and irisin serum levels in type 2 diabetic elderly men. Methods. This semi-experimental study was conducted on type 2 diabetic men with an average age of 70.85±2.90 years. The strength training protocol was performed twice a week for 21 weeks. The exercises consisted of three stages: 1- muscle endurance, 2- muscle hypertrophy, and 3- maximum strength training. Fasting blood glucose levels and serum levels of insulin, betatrophin, and irisin were measured in two phases before and after the exercises. Results. The serum levels of insulin, irisin, and betatrophin in the diabetes control group were lower than in the healthy group (P&lt;0.05) and 21 weeks of strength training increased the serum levels of insulin, irisin, and betatrophin, and decreased body weight and fasting blood glucose levels in elderly diabetic men compared to the control group (P&lt;0.05). Conclusion. Strength training improved metabolic disorders in diabetics and increased secretion of irisin and betatrophin following exercise which indicated that exercise may have a protective mechanism in diabetes. Practical Implications. Stationary movements by performing strength activities, through the development of skeletal muscles of diabetics, improve insulin sensitivity and harvest more glucose in the body. In addition, these exercises can be a protective mechanism to prevent or delay the complications of type 2 diabetes by increasing irisin and betatrophin levels.